###begin article-title 0
###xml 70 78 <span type="species:ncbi:9606">Children</span>
Clinical Implications of Serum Retinol-Binding Protein 4 in Asthmatic Children
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*These authors contributed equally to this work.
###end p 1
###begin p 2
###xml 884 886 884 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 334 342 <span type="species:ncbi:9606">children</span>
Recently the prevalence of both asthma and obesity have increased substantially in many countries. The aim of this study was to evaluate the role of retinol-binding protein (RBP) 4 in childhood asthma and its association with atopy markers, pulmonary function, and bronchial hyperresponsiveness in relation to obesity. We studied 160 children between the ages 6 to 10 yr, including 122 asthmatics and 38 controls. The body mass index, pulmonary function tests, and methacholine challenge tests were measured on the same day. Total eosinophil count, serum total IgE, serum eosinophil cationic protein, and serum RBP4 were measured in all subjects. There was no difference in serum RBP4 levels between the asthmatics and the control group. In all subjects or subgroups, serum RBP4 was not associated with total eosinophil count, serum total IgE, serum eosinophil cationic protein, or PC20. There was no relationship between serum RBP4 and pulmonary function in female asthmatics. Forced expiratory volume in 1 second/forced vital capacity (FVC) and forced expiratory flow between 25% and 75% of FVC contributed to serum RBP4 in male asthmatics. Our findings show an association between RBP4 and pulmonary function in prepubertal male asthmatics. This relationship may indirectly affect the high prevalence of childhood asthma in males.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 505 506 505 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 54 62 <span type="species:ncbi:9606">children</span>
###xml 135 143 <span type="species:ncbi:9606">children</span>
###xml 285 291 <span type="species:ncbi:9606">people</span>
Asthma is one of the most common chronic illnesses in children, and obesity is another important public health problem that can affect children (1, 2). Recently the prevalence of both asthma and obesity have increased substantially in many countries, leading to speculation that obese people might be at an increased risk of developing asthma (3, 4). Although a large number of studies have been performed, the possibility that obesity might increase the risk of asthma development remains controversial (5). Nevertheless, potential mechanisms have been suggested that obesity-related changes in lung volumes, systemic inflammation, and other adipocyte-derived factors such as leptin, adiponectin, resistin, and visfatin, as well as cytokines and chemokines that might alter smooth muscle function in such a way as to promote airway narrowing (2, 6).
###end p 4
###begin p 5
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 844 845 844 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 945 946 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1087 1089 1087 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1264 1266 1264 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1364 1366 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1501 1503 1501 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 804 809 <span type="species:ncbi:9606">human</span>
###xml 814 820 <span type="species:ncbi:10090">murine</span>
###xml 935 943 <span type="species:ncbi:9606">children</span>
###xml 1020 1025 <span type="species:ncbi:9606">human</span>
###xml 1069 1074 <span type="species:ncbi:9606">human</span>
Asthma is recognized as a chronic inflammatory disease in the airways (7), and the obese state is characterized by low-grade systemic inflammation, as indicated by increased levels of the inflammatory markers c-reactive protein (CRP) and IL-6 in the circulation of obese subjects (6). The effects of increased body mass index (BMI) on asthma may be mediated by upregulation of inflammatory mechanisms in the airway epithelium (8). The current view of adipose tissue is that of an active secretory organ, sending out and responding to signals that modulate appetite, energy expenditure, insulin sensitivity, endocrine and reproductive systems, bone metabolism, and inflammation and immunity (6). The serum concentrations of many adipokines could impact airway function, which might lead to asthma in both human and murine subjects with obesity (9). A recent study showed that leptin, an adipokine, might play a role in atopic asthma in children (8). Retinol-binding protein (RBP) 4 is highly expressed in isolated mature human adipocytes and secreted by differentiating human adipocytes (10). Previous studies have reported significant associations between RBP4 levels and BMI (11, 12). In contrast, other studies have not found a link between RBP4 levels and BMI (13, 14). Recent reports showed that RBP4 correlated with inflammatory factors such as CRP and IL-6 (15), and RBP4 mRNA had a strong positive correlation with markers of adipose inflammation (monocyte chemoattractant protein-1 and CD68) (16). Several studies have been reported on the relationship between RBP4 and obesity, adipose inflammation but, there has been no reports showing association between RBP4 and childhood asthma.
###end p 5
###begin p 6
We evaluated the role of RBP4 in childhood asthma and its association with atopy markers, pulmonary function, and bronchial hyperresponsiveness.
###end p 6
###begin title 7
MATERIALS AND METHODS
###end title 7
###begin title 8
Subjects
###end title 8
###begin p 9
###xml 362 364 362 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 452 453 450 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 476 477 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 558 560 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 567 579 <span type="species:ncbi:9606">participants</span>
###xml 648 656 <span type="species:ncbi:9606">Children</span>
###xml 780 792 <span type="species:ncbi:9606">participants</span>
###xml 818 826 <span type="species:ncbi:9606">children</span>
One hundred sixty prepubertal subjects, aged from 6 to 10 yr, were recruited from Severance Hospital, Yonsei University College of Medicine. Asthma was defined as recurrent wheezing or coughing episodes in the absence of common cold in the preceding 12 months. Additionally a physician's diagnosis of bronchial hyperresponsiveness upon methacholine challenge (PC20</=16 mg/mL) and at least 12% reversibility of forced expiratory volume in 1 second (FEV1) after inhaling a beta2 agonist, as per criteria of the American Thoracic Society (ATS), were required (17). All participants were enrolled before administering oral or inhaled corticosteroids. Children with history of asthma attacks requiring systemic corticosteroids within the preceding 6 months were excluded. The control participants were age-matched healthy children who visited the hospital for a general health work-up or vaccination and had no history of wheezing, recurrent chronic disease, infection during the preceding two weeks, or hypersensitivity to methacholine.
###end p 9
###begin p 10
###xml 88 89 88 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 296 304 <span type="species:ncbi:9606">children</span>
###xml 508 520 <span type="species:ncbi:9606">participants</span>
Height and weight were measured in light clothing without shoes to calculate BMI in kg/m2. Obesity and overweight classification were defined by BMI for age and sex based on an international survey (18). Absolute BMI values were then converted to previously established BMI percentiles of Korean children for data analysis (19). The 85th and 95th percentiles of BMI for age and sex were used as cut off values to identify normal weight, overweight and obesity. Informed written consent was obtained from all participants before inclusion in the study. The study was approved by the Severance Hospital Institutional Review Board beforehand.
###end p 10
###begin title 11
Spirometry and methacholine challenge test
###end title 11
###begin p 12
###xml 43 46 43 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 320 321 320 321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 624 625 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 689 690 689 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 801 802 801 802 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 806 808 806 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 876 878 876 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 188 200 <span type="species:ncbi:9606">participants</span>
###xml 237 245 <span type="species:ncbi:9606">Children</span>
Lung function was measured by spirometry (Vmax encore; VIASYS Healthcare Inc., Conshohocken, PA, U.S.A.) according to ATS standards (17). Bronchial hyperresponsiveness was assessed in all participants by the methacholine challenge test. Children were eligible if they could perform reproducible spirometry and had an FEV1 of at least 70% of the predicted value (20). In short, after saline inhalation, doses of methacholine (0.075, 0.15, 0.31, 0.62, 1.25, 2.5, 5, 10, and 25 mg/mL) were delivered for 0.6 sec through a DeVilbiss 646 nebulizer using a Rosenthal-French dosimeter (Ferraris, Hertford, England) until either FEV1 decreased by 20% or more, or the highest dose administered. FEV1 was measured 60 to 90 sec after each inhalation. The methacholine concentration inducing a 20% decrease in FEV1 (PC20) was recorded. The challenge test was considered positive if the PC20 was 16 mg/mL or less. Anti-inflammatory preparations and bronchodilators were withheld for 24 hr before the test.
###end p 12
###begin title 13
Measurement of blood eosinophils, serum total IgE, serum eosinophil cationic protein (ECP) and serum RBP4 levels
###end title 13
###begin p 14
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 512 517 <span type="species:ncbi:9606">human</span>
The NE-8000 system (Sysmex, Kobe, Japan) was used to count eosinophils automatically in peripheral blood. Serum total IgE and ECP were measured by the CAP radioallergosorbent technique (UniCAP; Pharmacia and Upjohn, Uppsala, Sweden). Blood samples to measure serum RBP4 levels were obtained between 6 a.m. and 9 a.m. after an overnight fast. After clotting at 4℃, the serum was separated by centrifugation at 1,300 g for 10 min and stored at -70℃ until the assays. Serum RBP4 concentrations were measured with a human RBP4 Competitive ELISA Kit (AdipoGen, Seoul, Korea) according to the manufacturer's instructions. The minimum RBP4 detection limit was 1 ng/mL and all assays were performed in duplicate for each sample, with the mean values reported here.
###end p 14
###begin title 15
Statistical analysis
###end title 15
###begin p 16
###xml 295 296 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 301 302 299 300 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 386 392 384 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 397 399 395 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 461 462 459 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Descriptive statistics were calculated as the mean+/-SD or as median (interquartile range) for continuous variables. Comparisons between groups were made using a Student's t-test, Mann-Whitney U test or chi-square test. Simple linear regression analysis was performed to assess the age, BMI, FEV1, FEV1/forced vital capacity (FVC), forced expiratory flow between 25% and 75% of FVC (FEF25-75%), PC20, eosinophil count, serum total IgE and ECP on RBP4 levels. A P value less than 0.05 was considered statistically significant. All analyses were performed on the Statistical Package for the Social Sciences software (version 13.0, SPSS Inc, Chicago, IL, U.S.A.).
###end p 16
###begin title 17
RESULTS
###end title 17
###begin p 18
###xml 429 435 427 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 505 512 503 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 581 582 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 591 598 589 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 65 77 <span type="species:ncbi:9606">participants</span>
###xml 95 99 <span type="species:ncbi:9606">boys</span>
###xml 115 120 <span type="species:ncbi:9606">girls</span>
###xml 252 260 <span type="species:ncbi:9606">children</span>
###xml 262 266 <span type="species:ncbi:9606">Boys</span>
The study included 122 patients with asthma and 38 controls. The participants consisted of 102 boys (63.8%) and 58 girls (36.2%) (mean age, 8.6+/-1.2 yr). The mean values for age and BMI percentile were not different between the asthmatics and healthy children. Boys were more predominant in the asthmatic group. Eosinophil count, serum total IgE and ECP were statistically higher in the asthmatics than the control subjects. FEF25-75% was significantly lower in the asthmatics than the control subjects (Table 1). In asthmatics, there was no gender difference in asthma severity (P=0.256) (Table 2).
###end p 18
###begin p 19
###xml 38 44 38 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 190 191 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The mean RBP4 concentration, shown in Fig. 1, was not significantly different between the asthmatics and control subjects (mean+/-SD, 256.91+/-93.37 microg/mL vs. 264.20+/-151.79 microg/mL, P=NS).
###end p 19
###begin p 20
###xml 152 153 152 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 168 174 168 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 181 183 181 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sub>
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 283 284 283 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 296 302 296 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 715 721 715 721 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 831 832 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 841 847 841 847 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 351 355 <span type="species:ncbi:9606">boys</span>
###xml 473 478 <span type="species:ncbi:9606">girls</span>
Simple linear regression analysis was performed with RBP4 as the dependent variable and age, BMI percentile, eosinophil count, serum total IgE, ECP, FEV1, FEV1/FVC, FEF25-75% and PC20 as the independent variables for asthmatics divided by sex (Table 3). The results indicate that FEV1/FVC and FEF25-75% contribute significantly to serum RBP4 level in boys with asthma. No other parameters were shown to contribute to RBP4. No variables significantly contributed to RBP4 in girls with asthma. In normal weight, overweight, and obesity group, no variables were correlated to RBP4 in both sexes and between the asthmatics and the control subjects (data not shown). According to asthma severity, serum total IgE and FEF25-75% contribute to serum RBP4 only in mild asthma group (data not shown). In male asthmatics, serum total IgE, FEV1, and FEF25-75% also contribute significantly to serum RBP4 in mild group (data not shown). No variables were associated with serum RBP4 in moderate and severe group both in all and male asthmatics (data not shown).
###end p 20
###begin title 21
DISCUSSION
###end title 21
###begin p 22
###xml 392 393 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 405 411 405 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
The aim of this study was to investigate serum RBP4 levels and its relationship between the parameters of atopy, pulmonary function, and bronchial hyperresponsiveness. There were no differences in mean serum RBP4 concentrations between the asthmatics and the control subjects. There was also no significant correlation between serum RBP4 and BMI for both the asthmatics and control group. FEV1/FVC and FEF25-75% contributed to serum RBP4 levels in male asthmatics.
###end p 22
###begin p 23
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1477 1478 1473 1474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1607 1609 1603 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1727 1729 1723 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1877 1879 1873 1875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1959 1961 1955 1957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1963 1965 1959 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1967 1969 1963 1965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 2064 2066 2060 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 695 701 <span type="species:ncbi:9606">people</span>
###xml 753 759 <span type="species:ncbi:9606">people</span>
###xml 1710 1714 <span type="species:ncbi:10090">mice</span>
###xml 1719 1725 <span type="species:ncbi:9606">humans</span>
###xml 1949 1957 <span type="species:ncbi:9606">patients</span>
There are several proposed mechanisms by which obesity can affect airway function (21). A recent review touched on the mechanical, immunological, hormonal and inflammatory effects of obesity that may play a role in the development and persistence of asthma (21, 22). Although a large number of cross-sectional, case-control, prospective and weight loss studies have been performed, the possibility that obesity might increase the risk of asthma development still remains controversial (3, 21). Our findings suggest that there is no direct association between BMI and asthma. Although a small study sample and a relatively small obese group may have affected the results, the proportion of obese people in our study is similar to the proportion of obese people in the general Korean population. Both the low proportion of obesity and the rarity of severe obesity in Korea may also have affected the results. The fact that the subjects were prepubertal (younger than 10 yr) may also have influenced the results by excluding the effects of sex hormones. Although the possibility that obesity might increase the risk of asthma remains controversial, their correlation is still a matter of concern. It is well documented that obesity is an inflammatory state that leads to increased levels of hormones such as leptin, cytokines such as interleukin-6 and tumor necrosis factor-alpha, chemokines and other inflammatory mediators that could potentially influence airway smooth muscle (6). RBP4 is a newly discovered fat-derived peptide that modulates glucose metabolism and consequently induces insulin resistance (23). A recent report suggests that RBP4 is a central mediator of obesity-induced insulin resistance in mice and humans (24). Mean serum RBP4 levels were elevated in both nondiabetic and diabetic obese subjects, and serum RBP4 levels were positively correlated with BMI (25). Previous studies have shown that RBP4 levels are elevated in obese patients (12, 24, 25). On the other hand, another report showed no association between plasma RBP4 levels and BMI (13). Our results show that serum RBP4 is not related to BMI. RBP4 level was not different between the asthmatics and normal control groups, and there were no differences in BMI between the asthmatics and controls in our study. The relatively narrow BMI distribution of our study subjects might explain the lack of a relationship.
###end p 23
###begin p 24
###xml 56 57 56 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 69 75 69 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 148 149 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 227 228 227 228 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 487 493 487 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
###xml 673 674 673 674 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1119 1121 1119 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1265 1266 1265 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 1005 1009 <span type="species:ncbi:9606">boys</span>
###xml 1090 1095 <span type="species:ncbi:9606">girls</span>
###xml 1189 1193 <span type="species:ncbi:9606">boys</span>
Simple linear regression analysis revealed that both FEV1/FVC and FEF25-75% are predictive factors of RBP4 for male asthmatics in our study. The FEV1 to FVC ratio is a useful assessment of airflow limitation (26). Recently, FEV1/FVC was reported to be a predictive factor for basement membrane thickness, which is a known early airway remodeling marker (27). Among the respiratory indices derived from the forced vital capacity maneuver, maximal midexpiratory flow rate (MMEF) namely FEF25-75%, which measures the average flow of gas through the middle lung volumes, was originally considered a more sensitive and earlier marker of obstruction in the small airways than FEV1 (28, 29). Our findings show that these two parameters contribute to serum RBP4 levels. The relationship between serum RBP4 and pulmonary function might be indirectly associated with lung inflammation, changes in small airways, and airflow obstruction, all part of asthma pathogenesis. It is known that asthma is more prevalent in boys younger than 10 yr or the mid-teens, at which point asthma is more prevalent in girls until sexual maturity (30). A current study shows that high serum leptin levels in asthmatic boys may partly explain the higher prevalence of childhood asthma in males (8). Our results support this phenomenon. No explanation for the phenomenon has been given. The often hypothesized role of sexual hormones still remains to be demonstrated (30).
###end p 24
###begin p 25
###xml 152 160 <span type="species:ncbi:9606">children</span>
###xml 200 212 <span type="species:ncbi:9606">participants</span>
Our research establishes the first causal relationship between serum RBP4 and asthma. We excluded the effects of sex hormones by recruiting prepubertal children as study subjects. The small number of participants and the relatively small obese group are limitations of this study. Relatively small number of female asthmatics may also have affected the results.
###end p 25
###begin p 26
In conclusion, our findings suggest an association between RBP4 and pulmonary function in prepubertal male asthmatics. This relationship may indirectly affect the high prevalence of childhood asthma in males.
###end p 26
###begin p 27
###xml 31 79 31 79 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Korea Science and Engineering Foundation (KOSEF)</funding-source>
###xml 124 144 124 144 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R11-2007-040-01004-0</award-id>
This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MOST, R11-2007-040-01004-0).
###end p 27
###begin article-title 28
###xml 52 60 <span type="species:ncbi:9606">children</span>
Assessment of asthma severity and asthma control in children
###end article-title 28
###begin article-title 29
Obesity, smooth muscle, and airway hyperresponsiveness
###end article-title 29
###begin article-title 30
The epidemiology of obesity and asthma
###end article-title 30
###begin article-title 31
The relation between obesity and asthmatic airway inflammation
###end article-title 31
###begin article-title 32
Ghrelin and leptin: a link between obesity and allergy?
###end article-title 32
###begin article-title 33
Adipose tissue, adipokines, and inflammation
###end article-title 33
###begin article-title 34
Asthma. From bronchoconstriction to airways inflammation and remodeling
###end article-title 34
###begin article-title 35
Leptin: does it have any role in childhood asthma?
###end article-title 35
###begin article-title 36
Obesity and asthma
###end article-title 36
###begin article-title 37
###xml 29 34 <span type="species:ncbi:9606">human</span>
Retinol-binding protein 4 in human obesity
###end article-title 37
###begin article-title 38
###xml 142 150 <span type="species:ncbi:9606">children</span>
Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children
###end article-title 38
###begin article-title 39
Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents
###end article-title 39
###begin article-title 40
###xml 64 69 <span type="species:ncbi:9606">human</span>
Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes
###end article-title 40
###begin article-title 41
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Retinol binding protein-4 levels and clinical features of type 2 diabetes patients
###end article-title 41
###begin article-title 42
###xml 61 69 <span type="species:ncbi:9606">children</span>
Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation
###end article-title 42
###begin article-title 43
###xml 40 46 <span type="species:ncbi:9606">humans</span>
Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone
###end article-title 43
###begin article-title 44
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999
###end article-title 44
###begin article-title 45
###xml 39 44 <span type="species:ncbi:9606">child</span>
Establishing a standard definition for child overweight and obesity worldwide: international survey
###end article-title 45
###begin article-title 46
###xml 91 99 <span type="species:ncbi:9606">children</span>
Nationalwide study on body mass index, skinfold thickness, and arm circumference in Korean children
###end article-title 46
###begin article-title 47
###xml 73 81 <span type="species:ncbi:9606">children</span>
Normal predicted values of pulmonary function test in Korean school-aged children
###end article-title 47
###begin article-title 48
Paediatric asthma and obesity
###end article-title 48
###begin article-title 49
###xml 48 53 <span type="species:ncbi:9606">human</span>
Does obesity weigh heavily on the health of the human airway?
###end article-title 49
###begin article-title 50
Metabolism: a is for adipokine
###end article-title 50
###begin article-title 51
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
###end article-title 51
###begin article-title 52
Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects
###end article-title 52
###begin article-title 53
No. 95-3659
###end article-title 53
###begin article-title 54
###xml 54 62 <span type="species:ncbi:9606">children</span>
Basement membrane thickening and clinical features of children with asthma
###end article-title 54
###begin article-title 55
###xml 46 54 <span type="species:ncbi:9606">children</span>
Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates
###end article-title 55
###begin article-title 56
A reduction in maximum mid-expiratory flow rate. A spirographic manifestation of small airway disease
###end article-title 56
###begin article-title 57
Does puberty interfere with asthma?
###end article-title 57
###begin p 58
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 109 121 <span type="species:ncbi:9606">participants</span>
Serum RBP4 levels do not show any difference between the asthmatics and the controls in all, male and female participants (P>0.05). Data represent median values.
###end p 58
###begin p 59
###xml 45 57 <span type="species:ncbi:9606">participants</span>
Selected characteristics to asthma status of participants
###end p 59
###begin p 60
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 12 18 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
*mean+/-SD; daggermedian (interquartile range).
###end p 60
###begin p 61
###xml 59 60 59 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 131 137 131 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
BMI, body mass index; ECP, eosinophil cationic protein; FEV1, forced expiratory volume in 1 second, FVC, forced vital capacity; FEF25-75%, forced expiratory flow between 25% and 75% of forced vital capacity.
###end p 61
###begin p 62
Details of asthmatics
###end p 62
###begin p 63
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 65 71 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
*Severity of asthma was classified according to GINA guidelines; daggerMild asthma group includes mild intermittent and mild persistent asthma group.
###end p 63
###begin p 64
Simple linear regression analysis between RBP4 and variables in asthmatics
###end p 64
###begin p 65
In all analyses, the dependent variable was RBP4. All analyses are adjusted for age.
###end p 65
###begin p 66
###xml 195 196 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 267 273 267 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25-75%</sub>
B, unstandardized regression coefficient; SE, standard error; Beta, standardized; regression coefficient; BMI, body mass index; TEC, total eosinophil count; ECP, eosinophil cationic proteinl; FEV1, forced exporatory volume in 1 second, FVC, forced vital capacity; FEF25-75%, forced expiratory flow between 25% and 75% of forced vital capacity.
###end p 66

